Improving statin use in Black patients with heart disease
Official title: ACHIEVE
Funded at Duke University · NIH-10918278 · Data updated 2026-11-12
This study is working to help Black patients with heart disease take their cholesterol-lowering statin medications more regularly by having pharmacists team up with them and their doctors to overcome any challenges they face in sticking to their treatment.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Duke University NIH-funded |
| Lab location | 1 site (Durham, United States) |
| Project start | September 1, 2023 |
| Project end | August 31, 2025 |
| Funding year | 2024 |
| Award (this year) | $323,551 |
| NIH project number | 5R34HL166680-02 |
| Project ID | NIH-10918278 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are Black individuals with a history of atherosclerotic cardiovascular disease who may not be receiving appropriate statin therapy.
✕Less likely to help
Patients who do not identify as Black or those without a history of atherosclerotic cardiovascular disease may not benefit from this research.
What this research studies
This research focuses on enhancing the use of statin medications among individuals with a history of atherosclerotic cardiovascular disease (ASCVD), particularly within the Black population. It involves a multi-center trial where pharmacists will collaborate with patients and their healthcare providers to address barriers to medication adherence and ensure appropriate statin therapy is initiated. By utilizing commercial payer records, eligible patients will be identified, and tailored interventions will be implemented to improve both prescription rates and adherence to statin therapy. The goal is to create a sustainable model that can be integrated into existing healthcare systems to benefit patients.
Why it matters
Potential benefit: If successful, this research could significantly increase the use of life-saving statin medications among Black patients with heart disease, ultimately reducing cardiovascular events and improving health outcomes.
How similar studies have gone: Previous research has shown that targeted interventions can improve medication adherence in specific populations, suggesting that this approach may be effective.
Where this research is happening
-
Duke University
Durham, United States Active
Researchers
- Principal investigator: Granger, Christopher B. — Duke University
- Study coordinator: Granger, Christopher B.
Related research
Other NIH-funded projects on the same topics.
-
Investigating genetic factors in Lewy body diseases
This study is looking at how changes in a specific gene might play a role in conditions like Parkinson's disease and dementia, so that people can better understand how their genetics affect their health and possibly find more tailored treatments.
-
Targeting the PAX3-FOXO1 protein in a deadly childhood cancer
This study is looking at a specific protein that helps a tough childhood cancer called alveolar rhabdomyosarcoma, with the goal of finding new ways to treat kids who have this illness.
-
Improving population health by studying reproduction and development
This study is looking at how different things in our environment can impact pregnancy and the health of babies, and it’s for people who are planning to have children or are already parents, as it aims to help improve understanding and outcomes for everyone involved.
-
Modeling axon degeneration in C. elegans to help ALS patients
Researchers are using a tiny worm model to uncover how axons break down, which could point to new ways to help people with ALS and related nerve diseases.
-
Induced Suppression of Platelet Activity in Aneurysmal SAH Management
A new approach tests whether carefully reducing platelet activity can improve outcomes after aneurysmal subarachnoid hemorrhage.
-
AI-enhanced virtual reality tool to support remote emergency brain surgery training in Tanzania
A new AI-powered virtual reality tool helps non-experts in low-resource areas get real-time remote guidance for emergency traumatic brain injury surgery.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.